New Results
VRK1 is a Paralog Synthetic Lethal Target in VRK2-methylated Glioblastoma
Julie A. Shields, Samuel R. Meier, Madhavi Bandi, Maria Dam Ferdinez, Justin L. Engel, Erin E. Mulkearns-Hubert, Nicole Hajdari, Kelly Mitchell, Wenhai Zhang, Shan-chuan Zhao, Minjie Zhang, Robert Tjin Tham Sjin, Erik Wilker, Justin D. Lathia, Jannik N. Andersen, Yingnan Chen, Fang Li, Barbara Weber, Alan Huang, View ORCID ProfileNatasha Emmanuel
doi: https://doi.org/10.1101/2021.12.30.474571
Julie A. Shields
1Tango Therapeutics, Cambridge MA
Samuel R. Meier
1Tango Therapeutics, Cambridge MA
Madhavi Bandi
1Tango Therapeutics, Cambridge MA
Maria Dam Ferdinez
1Tango Therapeutics, Cambridge MA
Justin L. Engel
1Tango Therapeutics, Cambridge MA
Erin E. Mulkearns-Hubert
2Cleveland Clinic, Cleveland OH
Nicole Hajdari
2Cleveland Clinic, Cleveland OH
Kelly Mitchell
2Cleveland Clinic, Cleveland OH
Wenhai Zhang
1Tango Therapeutics, Cambridge MA
Shan-chuan Zhao
1Tango Therapeutics, Cambridge MA
Minjie Zhang
1Tango Therapeutics, Cambridge MA
Robert Tjin Tham Sjin
1Tango Therapeutics, Cambridge MA
Erik Wilker
1Tango Therapeutics, Cambridge MA
Justin D. Lathia
2Cleveland Clinic, Cleveland OH
Jannik N. Andersen
1Tango Therapeutics, Cambridge MA
Yingnan Chen
1Tango Therapeutics, Cambridge MA
Fang Li
1Tango Therapeutics, Cambridge MA
Barbara Weber
1Tango Therapeutics, Cambridge MA
Alan Huang
1Tango Therapeutics, Cambridge MA
Natasha Emmanuel
1Tango Therapeutics, Cambridge MA
Article usage
Posted January 01, 2022.
VRK1 is a Paralog Synthetic Lethal Target in VRK2-methylated Glioblastoma
Julie A. Shields, Samuel R. Meier, Madhavi Bandi, Maria Dam Ferdinez, Justin L. Engel, Erin E. Mulkearns-Hubert, Nicole Hajdari, Kelly Mitchell, Wenhai Zhang, Shan-chuan Zhao, Minjie Zhang, Robert Tjin Tham Sjin, Erik Wilker, Justin D. Lathia, Jannik N. Andersen, Yingnan Chen, Fang Li, Barbara Weber, Alan Huang, Natasha Emmanuel
bioRxiv 2021.12.30.474571; doi: https://doi.org/10.1101/2021.12.30.474571
VRK1 is a Paralog Synthetic Lethal Target in VRK2-methylated Glioblastoma
Julie A. Shields, Samuel R. Meier, Madhavi Bandi, Maria Dam Ferdinez, Justin L. Engel, Erin E. Mulkearns-Hubert, Nicole Hajdari, Kelly Mitchell, Wenhai Zhang, Shan-chuan Zhao, Minjie Zhang, Robert Tjin Tham Sjin, Erik Wilker, Justin D. Lathia, Jannik N. Andersen, Yingnan Chen, Fang Li, Barbara Weber, Alan Huang, Natasha Emmanuel
bioRxiv 2021.12.30.474571; doi: https://doi.org/10.1101/2021.12.30.474571
Subject Area
Subject Areas
- Biochemistry (11755)
- Bioengineering (8757)
- Bioinformatics (29209)
- Biophysics (14980)
- Cancer Biology (12103)
- Cell Biology (17416)
- Clinical Trials (138)
- Developmental Biology (9425)
- Ecology (14187)
- Epidemiology (2067)
- Evolutionary Biology (18314)
- Genetics (12246)
- Genomics (16807)
- Immunology (11870)
- Microbiology (28101)
- Molecular Biology (11599)
- Neuroscience (60995)
- Paleontology (452)
- Pathology (1872)
- Pharmacology and Toxicology (3238)
- Physiology (4961)
- Plant Biology (10429)
- Synthetic Biology (2887)
- Systems Biology (7341)
- Zoology (1651)